详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Hu, Man[1] * ; Zhang, Shichuan[2]

; Han, Yaqian[3] ; Wu, Hui[4] ; Gao, Jin[5] ; Wu, Haijun[6] ; Lin, Qin[7] ; Shang, Wei[8] ; Li, Xia[9] ; Feng, Hong[10] ; Qiao, Qiao[11] ; Hu, Guangyuan[12] ; Yang, Kunyu[13] ; Song, Xicheng[14] ; Cao, Yuandong[15] ; Kang, Min[16] ; Wang, Ruozheng[17] ; Yu, Jinming[1] ;

机构： [1]Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China [2]Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China [3]Department of Radiation Oncology, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China [4]Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China [5]Department of Radiation Oncology, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China [6]Department of Oncology, Xiangya Hospital, Central South University, Changsha, China [7]Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China [8]Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Qingdao University, Qingdao, China [9]Department of Head and Neck Radiotherapy, Cancer hospital of Dalian university of technology, Liaoning cancer hospital & institute, Shenyang, China [10]Cancer Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China [11]Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, China [12]Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [13]Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [14]Department of Otorhinolaryngology, Head and Neck Surgery, Yuhuangding Hospital, Qingdao University, Yantai, China [15]Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [16]Department of Radiation Oncology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China [17]Department of Head and Neck Cancer Radiotherapy, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China

出处：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2024]版：

无

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2024]版：

无

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

A multicenter, retrospective study analysis: Evaluating the efficacy and safety of pembrolizumab in the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma

文献详情